Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-074818
Filing Date
2025-05-19
Accepted
2025-05-19 21:36:55
Documents
1
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 32336
  Complete submission text file 0000950170-25-074818.txt   33809
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Issuer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CABALETTA BIO, INC. 2929 ARCH STREET, SUITE 600 PHILADELPHIA PA 19104
Business Address
Marda Anup (Reporting) CIK: 0001790410 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39103 | Film No.: 25966013